Filing Details

Accession Number:
0001179110-13-017622
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-09 17:25:55
Reporting Period:
2013-12-05
Filing Date:
2013-12-09
Accepted Time:
2013-12-09 17:25:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1573318 D Charles Foltz 100 Abbott Park Road
Abbott Park IL 60064
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2013-12-05 587 $24.73 54,535 No 4 M Direct
Common Shares Without Par Value Acquisiton 2013-12-05 1,443 $24.72 55,978 No 4 M Direct
Common Shares Without Par Value Disposition 2013-12-05 1,716 $37.03 54,262 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Disposition 2013-12-05 587 $0.00 587 $24.73
Common Shares Option (right to buy) Disposition 2013-12-05 1,443 $0.00 1,443 $24.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-02-12 2014-02-19 No 4 M Direct
0 2011-03-15 2014-02-19 No 4 M Direct
Footnotes
  1. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.